Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based VITEK MS System for the Identification of Acinetobacter Species from Blood Cultures: Comparison with VITEK 2 and MicroScan Systems

Background Acinetobacter species are the leading cause of bloodstream infection (BSI), but their correct identification is challenging. We evaluated the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based VITEK MS (bioMérieux, France), and two automated systems, VITEK 2 (bioMérieux) and MicroScan (Siemens, USA) for identification of Acinetobacter BSI isolates. Methods A total of 187 BSI isolates recovered at a university hospital in Korea between 2010 and 2012 were analyzed. The identification results obtained using VITEK MS and two automated systems were compared with those of rpoB sequencing. Results Of 187 isolates analyzed, 176 were identified to the species level by rpoB sequencing: the Acinetobacter baumannii group (ABG; 101 A. baumannii, 43 A. nosocomialis, 10 A. pittii isolates) was most commonly identified (82.4%), followed by Acinetobacter genomic species 13BJ/14TU (5.3%), A. ursingii (2.1%), A. soli (2.1%), A. bereziniae (1.1%), and A. junii (1.1%). Correct identification rates to the species group (ABG) level or the species level was comparable among the three systems (VITEK MS, 90.3%; VITEK 2, 89.2%; MicroScan, 86.9%). However, VITEK MS generated fewer misidentifications (0.6%) than VITEK 2 (10.8%) and MicroScan (13.1%) (P<0.001). In addition, VITEK MS demonstrated higher specificity (100%) for discrimination between ABG and non-ABG isolates than the other systems (both, 31.8%) (P<0.001). Conclusions The VITEK MS system is superior to the VITEK 2 and MicroScan systems for identification of Acinetobacter BSI isolates, with fewer misidentifications and better discrimination between the ABG and non-ABG isolates.

[1]  K. Moriya,et al.  Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  S. Richter,et al.  Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli , 2013, European Journal of Clinical Microbiology and Infectious Diseases.

[3]  S. Suh,et al.  Identification, Genotypic Relation, and Clinical Features of Colistin-Resistant Isolates of Acinetobacter Genomic Species 13BJ/14TU from Bloodstreams of Patients in a University Hospital , 2014, Journal of Clinical Microbiology.

[4]  Z. Zdráhal,et al.  Improvement of MALDI-TOF MS profiling for the differentiation of species within the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. , 2013, Systematic and applied microbiology.

[5]  S. Suh,et al.  Accuracy of Species-Level Identification of Yeast Isolates from Blood Cultures from 10 University Hospitals in South Korea by Use of the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Vitek MS System , 2013, Journal of Clinical Microbiology.

[6]  É. Oswald,et al.  Performances of the Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System for Rapid Identification of Bacteria in Routine Clinical Microbiology , 2012, Journal of Clinical Microbiology.

[7]  R. Wenzel,et al.  Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. , 2012, The Journal of infection.

[8]  D. Yong,et al.  Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens , 2011, Yonsei medical journal.

[9]  C. Liao,et al.  Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. , 2011, The Journal of antimicrobial chemotherapy.

[10]  A. Sundsfjord,et al.  Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. , 2011, The Journal of antimicrobial chemotherapy.

[11]  Yee-Chun Chen,et al.  Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Turton,et al.  Incidence of Acinetobacter Species Other than A. baumannii among Clinical Isolates of Acinetobacter: Evidence for Emerging Species , 2010, Journal of Clinical Microbiology.

[13]  D. Raoult,et al.  Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. , 2009, Microbiology.

[14]  Mi Sun Kim,et al.  Acinetobacter soli sp. nov., isolated from forest soil , 2008, The Journal of Microbiology.

[15]  Harald Seifert,et al.  Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.

[16]  M. Vaneechoutte,et al.  Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986. , 2008, International journal of systematic and evolutionary microbiology.

[17]  M. Millar,et al.  Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[19]  D. Raoult,et al.  Sequencing of the rpoB Gene and Flanking Spacers for Molecular Identification of Acinetobacter Species , 2006, Journal of Clinical Microbiology.

[20]  D. Raoult,et al.  rpoB Gene Sequencing for Identification of Corynebacterium Species , 2004, Journal of Clinical Microbiology.

[21]  L. Dijkshoorn,et al.  Evaluation of the ability of a commercial system to identifyAcinetobacter genomic species , 1996, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  P. Gerner-Smidt,et al.  Reliability of phenotypic tests for identification of Acinetobacter species , 1991, Journal of clinical microbiology.

[23]  M. Vaneechoutte,et al.  Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. , 2009, International journal of systematic and evolutionary microbiology.